SCHEMBL8036851

SCHEMBL8036851

IC1c2ccccc2C=Cc2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.50
KDM4E B2RXH2 5/20 0.39
CYP2D6 P10635 3/20 0.39
HSD17B10 Q99714 3/20 0.39
TP53 P04637 2/20 0.39
CYP3A4 P08684 2/20 0.39
LMNA P02545 2/20 0.39
CHRM2 P08172 1/20 0.39
CHRM1 P11229 1/20 0.39
DRD2 P14416 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
NFKB1 P19838 1/20 0.39
CHRM3 P20309 1/20 0.39
SLC6A2 P23975 1/20 0.39
HTR2C P28335 1/20 0.39
ADRA1A P35348 1/20 0.39
HRH1 P35367 1/20 0.39
DRD3 P35462 1/20 0.39
THPO P40225 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21445826 0.78
SCHEMBL12983582 0.74 HTR2A (0.41) HTR2AKDM4ECYP2D6HSD17B10TP53
SCHEMBL29365389 0.74 HTR2A (0.41) HTR2AKDM4ECYP2D6HSD17B10TP53
SCHEMBL12532741 0.73 HTR2A (0.34) HTR2AKDM4ECYP2D6HSD17B10TP53
SCHEMBL6420010 0.72 HTR2A (0.50) HTR2AKDM4ECYP2D6HSD17B10TP53
SCHEMBL10080430 0.72 HTR2A (0.56) HTR2AKDM4ECYP2D6HSD17B10TP53
SCHEMBL11875463 0.72 BRD4 (0.53) HTR2AKDM4ECYP2D6HSD17B10TP53
SCHEMBL31099344 0.72 HTR2A (0.50) HTR2AKDM4ECYP2D6HSD17B10TP53
SCHEMBL5679950 0.72 HTR2A (0.50) HTR2AKDM4ECYP2D6HSD17B10TP53
SCHEMBL1276091 0.72 HTR2A (0.50) HTR2AKDM4ECYP2D6HSD17B10TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3770148-A1 RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF Beijing Tide Pharmaceutical Co., Ltd. (CN) 2021-01-27 EP disclosed
EP-3760620-A1 RECEPTOR ANTAGONIST, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USAGE THEREOF Beijing Tide Pharmaceutical Co., Ltd. (CN) 2021-01-06 EP disclosed
WO-2019179515-A1 RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF 北京泰德制药股份有限公司 2019-09-26 WO disclosed
WO-2009075857-A2 GLYCINE TRANSPORTER-1 INHIBITORS AMGEN INC. (US) 2009-06-18 WO disclosed